Additional effects of endothelin receptor blockade and angiotensin converting enzyme inhibition in rats with chronic heart failure

Acta Pharmacologica Sinica

Volumn 22, Issue 6, 2001, Pages 541-548

  Qiu, C ^a   Qiu, C S ^a   Hess, P ^a   Clozel, J P ^a   Clozel, M ^a  

^a SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Angiotensin converting enzyme inhibitors; Congestive heart failure; Enalapril; Endothelin receptors; Endothelins; Hemodynamics; Myocardial infarction; Tezosentan

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; ENDOTHELIN RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; TESOZENTAN; UNCLASSIFIED DRUG; ANGIOTENSIN CONVERTING ENZYME INHIBITORS; PYRIDINE DERIVATIVE; TETRAZOLE DERIVATIVE; TEZOSENTAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; HEART AFTERLOAD; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; HEART RATE; HEMODYNAMICS; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RECEPTOR BLOCKING; ANIMAL; BLOOD PRESSURE; CONGESTIVE HEART FAILURE; DRUG EFFECT; DRUG POTENTIATION; PATHOPHYSIOLOGY; RAT STRAIN;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMAL; BLOOD PRESSURE; DRUG SYNERGISM; ENALAPRIL; HEART FAILURE, CONGESTIVE; HEART RATE; HEMODYNAMICS; MALE; MYOCARDIAL INFARCTION; PYRIDINES; RATS; RATS, WISTAR; RECEPTORS, ENDOTHELIN; SUPPORT, NON-U.S. GOV'T; TETRAZOLES;

EID: 0034978114     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. The neurohumoral hypothesis: A theory to explain the mechanism of disease progression in heart failure
2. Hemodynamic effects of direct angiotensin II blockade compared to converting enzyme inhibition in rat model of heart failure
3. Effects of enalapril on survival in pateients with reduced left ventricular ejection fractions and congestive heart failure
4. Peripheral artery structure and endothelial function in heart failure: Effect of ACE inhibition
5. Persistent hemodynamic improvement with short-term nitrate therapy in patients with chronic congestive heart failure already treated with captopril
6. Endothelin in chronic heart failure: Current position and future prospects
7. Endothelin antagonist with bosentan: A review of potential applications
8. Short-term hemodynamic effects of endothelin receptor blockade in dogs with chronic heart failure
9. Concomitant endothelin receptor subtype-A blockade during the progression of pacing-induced congestive heart failure in rabbits. Beneficial effects on left ventricular and myocyte function
10. Role of endothelin in the maintenance of blood pressure in conscious rats with chronic heart failure: Acute effects of the endothelin receptor antagonist Ro 47-0203 (bosentan)
11. Relationship between endothelin-1 spillover in the lungs and the pulmonary vascular resistance in patients with chronic heart failure
12. Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure
13. Plasma endothelin determination as a proganostic indicator of 1-year mortality after acute myocardial infarction
14. Role of endogenous endothelin in chronic heart failure: Effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling
15. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure
16. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure
17. Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure
18. Pharmacology of tezosentan, new endothelin receptor antagonist designed for parenteral use
19. A receptor activation
20. Endothelin modulates the pressor actions of acute systemic nitric oxide blockade
21. Controlled trial of captopril in chronic heart failure. A rest and exercise hemodynamic study
22. B receptor mediates both vasodilation and vasoconstriction in vivo
23. A receptor blockade in chronic heart failure patients treated with ACE inhibitors
24. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental heart failure
25. Hemodynamic effect of endothelin antagonists in dogs with myocardial infarction